Back to Journals » Journal of Hepatocellular Carcinoma » Volume 8 » default

Journal of Hepatocellular Carcinoma


Archive: Volume 8, 2021

Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Chung SW, Park MK, Cho YY, Park Y, Lee CH, Oh H, Jang H, Kim MA, Kim SW, Nam JY, Lee YB, Cho EJ, Yu SJ, Kim HC, Kim YJ, Chung JW, Yoon JH, Lee JH

Journal of Hepatocellular Carcinoma 2021, 8:587-598

Published Date: 15 June 2021

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center

Karbeyaz F, Kissling S, Jaklin PJ, Bachofner J, Brunner B, Müllhaupt B, Winder T, Mertens JC, Misselwitz B, von Felten S, Siebenhüner AR

Journal of Hepatocellular Carcinoma 2021, 8:565-574

Published Date: 11 June 2021

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma

Zhou Z, Lin L, An Y, Zhan M, Chen Y, Cai M, Zhu X, Lu L, Zhu K

Journal of Hepatocellular Carcinoma 2021, 8:529-543

Published Date: 8 June 2021

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma

Moura Cunha G, Chernyak V, Fowler KJ, Sirlin CB

Journal of Hepatocellular Carcinoma 2021, 8:513-527

Published Date: 31 May 2021

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Monge C, Xie C, Steinberg SM, Greten TF

Journal of Hepatocellular Carcinoma 2021, 8:507-512

Published Date: 31 May 2021

Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications

Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY

Journal of Hepatocellular Carcinoma 2021, 8:493-505

Published Date: 28 May 2021

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC

Granito A, Marinelli S, Forgione A, Renzulli M, Benevento F, Piscaglia F, Tovoli F

Journal of Hepatocellular Carcinoma 2021, 8:477-492

Published Date: 26 May 2021

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B

Lee HW, Lee HW, Lee JS, Roh YH, Lee H, Kim SU, Park JY, Kim DY, Ahn SH, Kim BK

Journal of Hepatocellular Carcinoma 2021, 8:467-476

Published Date: 25 May 2021

The Mechanisms of HBV-Induced Hepatocellular Carcinoma

Jiang Y, Han Q, Zhao H, Zhang J

Journal of Hepatocellular Carcinoma 2021, 8:435-450

Published Date: 20 May 2021

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK

Journal of Hepatocellular Carcinoma 2021, 8:421-434

Published Date: 17 May 2021

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide

Müller L, Stoehr F, Mähringer-Kunz A, Hahn F, Weinmann A, Kloeckner R

Journal of Hepatocellular Carcinoma 2021, 8:403-419

Published Date: 13 May 2021

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options

Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M

Journal of Hepatocellular Carcinoma 2021, 8:387-401

Published Date: 13 May 2021

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma

Gramantieri L, Giovannini C, Piscaglia F, Fornari F

Journal of Hepatocellular Carcinoma 2021, 8:369-385

Published Date: 12 May 2021

Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation

Salman A, Salman M, Moustafa A, Shaaban HE, El-Mikkawy A, Labib S, Youssef A, Omar MG, Matter M, Elkassar H

Journal of Hepatocellular Carcinoma 2021, 8:313-320

Published Date: 29 April 2021

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma

Zhong Y, Yang Y, He L, Zhou Y, Cheng N, Chen G, Zhao B, Wang Y, Wang G, Liu X

Journal of Hepatocellular Carcinoma 2021, 8:301-312

Published Date: 29 April 2021

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection

Ye F, Huang W, Xue Y, Tang E, Wang M, Shi F, Wei D, Han Y, Chen P, Zhang X, Yu D

Journal of Hepatocellular Carcinoma 2021, 8:285-300

Published Date: 27 April 2021

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway

Liu G, Li J, Zhang CY, Huang DY, Xu JW

Journal of Hepatocellular Carcinoma 2021, 8:271-284

Published Date: 21 April 2021

Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors

Chen L, Liu ZX, Bi QC, Zhao J, Liang QR, Tang Q

Journal of Hepatocellular Carcinoma 2021, 8:263-270

Published Date: 20 April 2021

NAFLD-Associated HCC: Progress and Opportunities

Geh D, Anstee QM, Reeves HL

Journal of Hepatocellular Carcinoma 2021, 8:223-239

Published Date: 8 April 2021

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma

Guo X, Tian S, Cao P, Xie Y, Dong W

Journal of Hepatocellular Carcinoma 2021, 8:211-222

Published Date: 6 April 2021

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

Weng J, Zhou C, Zhou Q, Chen W, Yin Y, Atyah M, Dong Q, Shi Y, Ren N

Journal of Hepatocellular Carcinoma 2021, 8:193-209

Published Date: 29 March 2021

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges

D'Alessio A, Prete MG, Cammarota A, Personeni N, Rimassa L

Journal of Hepatocellular Carcinoma 2021, 8:177-191

Published Date: 29 March 2021

Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP

Journal of Hepatocellular Carcinoma 2021, 8:167-176

Published Date: 25 March 2021

Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections

Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M

Journal of Hepatocellular Carcinoma 2021, 8:133-143

Published Date: 18 March 2021

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma

Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S

Journal of Hepatocellular Carcinoma 2021, 8:119-132

Published Date: 16 March 2021

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)

Liang L, Wang MD, Zhang YM, Zhang WG, Zhang CW, Lau WY, Shen F, Pawlik TM, Huang DS, Yang T

Journal of Hepatocellular Carcinoma 2021, 8:103-118

Published Date: 12 March 2021

Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma

Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN

Journal of Hepatocellular Carcinoma 2021, 8:85-101

Published Date: 12 March 2021

Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model

Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF

Journal of Hepatocellular Carcinoma 2021, 8:71-83

Published Date: 9 March 2021

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ

Journal of Hepatocellular Carcinoma 2021, 8:57-69

Published Date: 3 March 2021

Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes

Shi T, Kobara H, Oura K, Masaki T

Journal of Hepatocellular Carcinoma 2021, 8:45-55

Published Date: 11 February 2021

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma

Ely A, Bloom K, Maepa MB, Arbuthnot P

Journal of Hepatocellular Carcinoma 2021, 8:1-17

Published Date: 27 January 2021